Evaluation of the Neoadjuvant Treatment With Oxaliplatin -UFT- Radiotherapy in Rectal Cancer

A Pilot Study Evaluating β-hydroxybutyrate Supplementation Concomitant to Short-Course Radiotherapy Followed by Immunotherapy Combined With CAPEOX Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer

NCT07239466 ·Status: RECRUITING ·Phase: PHASE2

Total Neoadjuvant Treatment Plus SHR1210 for High-risk Rectal Cancer and Biomarker Screening Base on Neoantigen

NCT04340401 ·Status: UNKNOWN ·Phase: PHASE2

Preoperative S-1/OHP With Radiation Therapy for Low-lying Rectal Carcinoma in Neo-adjuvant Setting

NCT01227239 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Neoadjuvant Short-course Radiotherapy Followed by the Combination of Immunotherapy and Chemotherapy in Locally Advanced Rectal Cancer

NCT04663763 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Preoperative Radiotherapy and E7046 in Rectum Cancer

NCT03152370 ·Status: COMPLETED ·Phase: PHASE1

Rectal Artery Infusion Chemotherapy Combined With Anti-PD1 Antibody for MSS LARC

NCT05307198 ·Status: UNKNOWN ·Phase: PHASE2

Capecitabine Versus Bolus 5-Fu Associated to Radiotherapy as Neoadjuvant Treatment for Rectal Cancer.

NCT03428529 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Study Comparing Adjuvant Chemotherapy Versus Observation for Patients With Rectal Adenocarcinoma After Neoadjuvant Chemo-Radiotherapy Treatment.

NCT01941979 ·Status: UNKNOWN ·Phase: PHASE3

Preoperative Chemoradiotherapy Combined With Consolidation or Induction NALIRIFOX in Rectal Cancer.

NCT06894797 ·Status: RECRUITING ·Phase: NA

Online Adaptive Radiation Therapy for Rectal Cancer

NCT05911789 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Neoadjuvant FOLFOX6 Chemotherapy With or Without Radiation in Rectal Cancer

NCT01211210 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Neoadjuvant Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer（CONTROL-01）

NCT06647680 ·Status: RECRUITING ·Phase: PHASE2

Randomized Controlled Study on Optimize Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer

NCT02031939 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Neoadjuvant Chemoradiotherapy Versus Neoadjuvant Chemotherapy For Unresectable Locally Advanced Colon Cancer

NCT03970694 ·Status: TERMINATED ·Phase: PHASE3

Short-course Radiotherapy Followed by Fruquintinib Plus Adebrelimab and CAPOX in the Full Course Neoadjuvant Treatment of Locally Advanced Rectal Cancer: a Multicenter, Single-arm, Open-label Study

NCT06234007 ·Status: RECRUITING ·Phase: PHASE2

Neoadjuvant Chemoradiotherapy Combined With Tislelizumab in the Treatment of Locally Advanced Rectal Cancer

NCT05479240 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Multicenter Single-arm P2 to Evaluate Safety and Efficacy of the Total Neoadjuvant Therapy for cT2 Rectal Cancer

NCT05939661 ·Status: RECRUITING ·Phase: PHASE2

Total Neoadjuvant Therapy With PD-1 for Locally Advcancer Rectal Cancer

NCT07214142 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Short-course Radiotherapy (5×6Gy/7Gy/8Gy) Followed by Neo-adjuvant Chemotherapy for Locally Advanced Rectal Cancer

NCT03466424 ·Status: RECRUITING

Adjuvant Chemotherapy in Patients With Clinical Stage III Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy

NCT03415763 ·Status: RECRUITING ·Phase: PHASE3

SHR-1701 in Combination With Chemotherapy and Radiotherapy in Locally Advanced Rectal Cancer

NCT05300269 ·Status: RECRUITING ·Phase: PHASE2

Detection and Enumeration of Circulating Tumor Cells in Rectal Cancer

NCT01671891 ·Status: UNKNOWN

Optimisation of Radiotherapy in Rectal Cancer (ORREC)

NCT04090450 ·Status: UNKNOWN

Efficacy, Safety and Exploratory Clinical Study of Bevacizumab Combined With Oxaliplatin and TAS-102 in First-line Treatment of Advanced Colorectal Cancer

NCT05364489 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Phase ll Study of Neoadjuvant Short-course Radiotherapy Followed by Ivonescimab and Chemotherapy in pMMR/MSS Locally Advanced Rectal Cancer

NCT06919510 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2